PLAN YOUR VIRTUAL PRESENTATION TODAY
PLAN YOUR VIRTUAL PRESENTATION TODAY
PLAN YOUR VIRTUAL PRESENTATION TODAY
Scott Lyman

Biotech Entrepreneur and Chief Executive Officer of Belhaven Biopharma
Scott Lyman, CEO and Co-Founder of Belhaven Biopharma, champions the mission of delivering accessible health care worldwide, with a particular focus on innovative allergy care. As Chairman of the Board, his leadership is rooted in a dedication to developing cutting-edge pharmaceutical solutions that address severe allergies through user-friendly dry powder nasal formulations. His extensive experience in the biopharmaceutical sector, including pivotal roles at GSK, BioCryst, Salix, and as Chief Business Officer at Grid Therapeutics, underpins his commitment to transforming emergency medication delivery systems. Scott's academic background in chemical engineering and business administration bolsters his ability to drive forward the global accessibility of essential medications.
KEYNOTE TOPICS
• Global Health Care Accessibility: Delivering Essential Allergy Treatments Worldwide
• Innovations In Allergy Care: Developing & Deploying User-Friendly Severe Allergy Treatments.
• Overcoming Pharmaceutical Challenges: Lessons From Global Regulations & Markets
• Leadership For Global Health Impact: Fostering Innovation & Strategic Growth